There will also be independent trials, sponsored by NICHD
(the National Institute of Child Health and Human Development -- a part of the NIH).
Note 10/16/98 entry at nih.gov
Last May, there was an announcement of an NICHD trial in the Seattle Times.
One-third of the patients will get porcine secretin, one-third synthetic, one-third placebo.
"Fifty-one children will participate in a study at the UW's Center on Human Development and Disability, beginning late this summer. An equal number will be part of a test group at the University of Colorado........
Before the treatment, each child will be evaluated through behavioral observation, language testing and a review of records and observations made by parents and teachers. A month after treatment, the evaluations will be repeated to measure any differences.
Unis said the researchers hope to have test results in six months to a year. If they look promising, more extensive, long-term studies will follow, he said."
archives.seattletimes.com
---------------------------------------------
Leading the study:
Alan Unis, director of the developmental neuropsychiatry clinic at the UW center
weber.u.washington.edu
Geraldine Dawson, a UW professor of psychology who is directing a national study on the causes of autism
weber.u.washington.edu |
